← Back to All Filings

Regeneron EVP Sells $3.0M in Stock for Tax Withholding

Low SignificanceDecember 11, 2025 at 5:06:36 PM EST

REGENERON PHARMACEUTICALS, INC.

$REGN4CIK: 0000872589

Subscribe to track REGN

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Regeneron EVP Sells $3.0M in Stock for Tax Withholding

Company: REGENERON PHARMACEUTICALS, INC. (REGN) Form: 4 | Filed: 2025-12-11 Significance: Low

Insider: MURPHY ANDREW J Title: EVP Research | Relationship: Officer

Transaction: • Type: Tax Withholding (Code F) • Shares: 4,229 • Price: $701.51 • Value: $2,966,611 • Owned After: 52,208 (Direct & Indirect)

Key Insight: This is a non-discretionary sale to cover tax obligations on vested shares, not an active market sale. It has minimal signaling value.

Market Context: The transaction represents a negligible fraction (<0.01%) of the company's $72.89B market cap and shares outstanding.

Comprehensive Analysis

SEC Filing Analysis: REGENERON PHARMACEUTICALS, INC. (REGN)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An executive at Regeneron disposed of shares in a non-discretionary transaction to cover tax liabilities, which is a routine event with no investment signal.
  • Market Impact: Negligible, as the transaction is automatic and immaterial in size.

Company Information

FieldValue
CompanyREGENERON PHARMACEUTICALS, INC.
Ticker SymbolREGN
CIK0000872589
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameMURPHY ANDREW J
CIK0001796226
Title/PositionEVP Research
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-09
Transaction CodeF - Payment of tax liability by withholding securities
Security TypeCommon Stock
Shares Involved4,229
Price Per Share$701.51
Total Value$2,966,610.79
Shares Owned After47,833 (Directly)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$2,966,610.79
% of Market Cap0.0041%
Shares Transacted4,229
% of Shares Outstanding0.0041%
Post-Transaction Ownership52,208 shares (0.05% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a large-cap company with a market capitalization of $72.89 billion, a transaction of approximately $3.0 million is financially immaterial.
  • Ownership Concentration: The insider's total post-transaction holding of 52,208 shares (including 4,375 held indirectly via a 401k plan) constitutes a very small fraction (0.05%) of the total shares outstanding.
  • Transaction Significance: The transaction's size is negligible relative to both market cap and shares outstanding. The 'F' code confirms it is a forced sale to cover taxes, not a discretionary decision reflecting the insider's sentiment about the company's future.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a routine, non-discretionary 'sell-to-cover' transaction for tax purposes. It does not reflect a change in the insider's outlook on the company and is not expected to influence the market.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The number of shares is too small to impact trading volume.
  • Sentiment Indicator: Neutral. The market typically disregards 'F' coded transactions as they are not indicative of insider sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The transaction code 'F' explicitly denotes that shares were withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock. This is not an open market sale.
Topics:#SECFiling#InsiderTrading#REGN#Regeneron#Form4#TaxWithholding#StockMarket#Finance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.